Cephea Valve Technologies
Cephea Valve Technologies is creating the first Catheter delivered Mitral Valve that is based on non-stent based anchoring technology.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location San Jose, CA, USA
- Currency USD
- Founded June 2011
- Employees 1
- Website cephea.com
Cephea Valve Technologies is developing an innovative approach to anchor a tissue mitral valve to the native mitral valve annulus. We will enable Cardiologists to deliver this mitral valve through a catheter in a much less invasive manner. Our patients do not need to have open heart surgery or general anesthesia, therefore they will not face the risks associated with open heart surgery or general anesthesia.
Thierry Bernard ThaureCo-Founder and Chief Executive Officer
Mr. Thaure is a senior executive with 30 years experience with medical devices as an entrepreneur and Chief Executive Officer. He demonstrated success in building businesses with disruptive technologies and driving their market expansion. Mr. Thaure played a key role in companies such as Origin MedSystems, Intuitive Surgical, Accuray, and EndoGastric Solutions. He has extensive experience in cardiac surgery and the early phase of angioplasty. Mr.
Fred MollChairman of the Board
Dr Fred Moll is the founder of a number of exciting companies that have revolutionized medicine. In 2003 he founded Hansen Medical, the first robotics heart catheter company. In 1995, Dr. Moll founded Intuitive Surgical (NASDAQ: ISRG), the world leader in surgical robotics, and served as the company’s first CEO. Prior to Intuitive Surgical, Dr. Moll co-founded Origin Medsystems, Inc., which later became an operating company within Guidant Corpora
Alaide ChieffoCo-Founder and Clinical Advisor
Dr. Chieffo is a full time interventional cardiologist specializing in advanced interventional procedures at the San Raffaele Hospital in Milan. She is also the Director of Research in Interventional Cardiology at San Raffaele Hospital and she is Scientific Director of the Master in Invasive Cardiology program at the University of Vita e Salute in Milan. Dr. Chieffo has won multiple research awards, authored more than 30 papers, and co-authored o
Juan GranadaCo-Founder and Clinical Advisor
Dr. Granada is an active interventional cardiologist specializing in advanced interventional procedures and is the Executive Director and Chief Scientific Officer of the Skirball Center for Cardiovascular Research at the CRF. Over the last 10 years, Dr. Granada has focused on testing new emerging technologies and has been the leading investigator of technologies such as Cardiac imaging, new Endovascular therapies and tissue regeneration.
Matteo MontorfanoCo-Founder and Clinical Advisor
Dr. Montorfano is a full time interventional cardiologist specializing in advanced interventional procedures in both cardiovascular and structural heart disease. He is also the cath lab Director at the San Raffaele Scientific Institute in Milan, Italy.
Jim ShayLawyerUnconfirmedBruce MizerAccountantUnconfirmed
Fred MollUnconfirmedAngel InvestorsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.